(S (NP (PRP We)) (VP (VBP propose) (NP (DT a) (NN hybrid) (JJ sequential) (NML (JJ deep) (NN learning)) (NN model)) (S (VP (TO to) (VP (VB predict) (NP (NP (DT the) (NN risk)) (PP (IN of) (NP (NNP AMD) (NN progression)))) (PP (IN in) (NP (NP (JJ non-exudative) (NNP AMD) (NNS eyes)) (PP (IN at) (NP (JJ multiple) (NNS timepoints))))) (, ,) (PP (VBG starting) (PP (IN from) (NP (NP (NML (JJ short) (HYPH -) (NN term)) (NN progression) (PRN (-LRB- -LRB-) (NP (NML (CD 3) (SYM -)) (NNS months)) (-RRB- -RRB-))) (ADVP (IN up) (PP (IN to) (NP (NML (JJ long) (HYPH -) (NN term)) (NN progression) (PRN (-LRB- -LRB-) (NP (NML (CD 21) (SYM -)) (NNS months)) (-RRB- -RRB-)))))))))))) (. .))
(S (NP (VBN Proposed) (NN model)) (VP (VBZ combines) (NP (NP (NNS radiomics)) (CC and) (NP (JJ deep) (NN learning))) (S (VP (TO to) (VP (VB handle) (NP (NP (NNS challenges)) (VP (VBN related) (PP (IN to) (NP (NP (ADJP (JJ imperfect)) (NN ratio)) (PP (IN of) (NP (NN OCT) (NML (NN scan) (NN dimension) (CC and) (NN training)) (NN cohort) (NN size))))))))))) (. .))
(S (S (NP (PRP We)) (VP (VBD considered) (NP (NP (DT a) (JJ retrospective) (JJ clinical) (NN trial) (NN dataset)) (SBAR (WHNP (WDT that)) (S (VP (VBZ includes) (NP (CD 671) (JJ fellow) (NNS eyes)) (PP (IN with) (NP (NP (CD 13,954) (JJ dry) (NNP AMD) (NNS observations)) (PP (IN for) (NP (NN training))))))))))) (CC and) (S (VP (VBG validating) (NP (DT the) (NML (NN machine) (NN learning)) (NNS models)) (PP (IN on) (NP (DT a) (RB 10-fold) (JJ cross) (NN validation) (NN setting))))) (. .))
(S (NP (NP (DT The) (VBN proposed) (NN RNN) (NN model)) (VP (VP (VBN achieved) (NP (NP (JJ high) (NN accuracy) (PRN (-LRB- -LRB-) (NP (CD 0.96) (NN AUCROC)) (-RRB- -RRB-))) (PP (IN for) (NP (NP (DT the) (NN prediction)) (PP (IN of) (NP (NML (CC both) (NML (JJ short) (NN term)) (CC and) (NML (JJ long) (HYPH -) (NN term))) (NNP AMD) (NN progression))))))) (, ,) (CC and) (VP (VBD outperformed) (NP (DT the) (JJ traditional) (NML (JJ random) (NN forest)) (NN model))))) (VP (VBN trained)) (. .))
(S (NP (NP (JJ High) (NN accuracy)) (VP (VBN achieved) (PP (IN by) (NP (DT the) (NN RNN))))) (VP (VBZ establishes) (NP (NP (DT the) (NN ability) (S (VP (TO to) (VP (VB identify) (NP (NNP AMD) (NNS patients)) (PP (IN at) (NP (NP (NN risk)) (PP (IN of) (S (VP (VBG progressing) (PP (IN to) (NP (JJ advanced) (NNP AMD))) (PP (IN at) (NP (NP (DT an) (JJ early) (NN stage)) (SBAR (WHNP (WDT which)) (S (VP (MD could) (VP (VB have) (NP (DT a) (JJ high) (JJ clinical) (NN impact)) (SBAR (IN as) (S (NP (PRP it)) (VP (VBZ allows) (PP (IN for) (NP (JJ optimal) (JJ clinical) (NML (NN follow) (HYPH -) (NN up)))))))))))))))))))))) (, ,) (PP (IN with) (NP (ADJP (RBR more) (JJ frequent)) (NN screening) (CC and) (NN potential))) (NP (ADVP (RBR earlier)) (NP (NN treatment)) (PP (IN for) (NP (DT those) (NNS patients))) (PP (IN at) (NP (JJ high) (NN risk)))))) (. .))
